Sotera Health (NASDAQ:SHC) Stock Gets Price Target Reduction from Barclays

Sotera Health (NASDAQ:SHC) had its price objective trimmed by Barclays from $22.00 to $20.00 in a research note published on Wednesday,Benzinga reports. The brokerage currently has an overweight rating on the stock.

SHC has been the topic of a number of other research reports. Weiss Ratings lowered Sotera Health from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, October 23rd. Citigroup increased their price objective on Sotera Health from $23.00 to $25.00 and gave the company a “buy” rating in a research report on Friday, August 7th. JPMorgan Chase & Co. downgraded shares of Sotera Health from a “neutral” rating to an “underweight” rating and set a $17.00 price objective on the stock. in a research note on Wednesday, October 14th. Piper Sandler reaffirmed an “overweight” rating and set a $25.00 target price on shares of Sotera Health in a research report on Tuesday, September 8th. Finally, Wall Street Zen upgraded shares of Sotera Health from a “buy” rating to a “strong-buy” rating in a research note on Sunday, October 25th. Eight investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $20.88.

Sotera Health Stock Performance

Sotera Health stock traded up $0.14 on Wednesday, reaching $16.01. 2,199,215 shares of the stock were exchanged, compared to its average volume of 2,134,572. The stock has a market cap of $4.57 billion, a PE ratio of 26.68 and a beta of 1.94. The company has a current ratio of 2.80, a quick ratio of 2.55 and a debt-to-equity ratio of 3.33. Sotera Health has a twelve month low of $13.09 and a twelve month high of $19.85. The firm has a fifty day moving average price of $18.22 and a two-hundred day moving average price of $16.97.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings results on Tuesday, November 3rd. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.02. The company had revenue of $324.89 million for the quarter, compared to the consensus estimate of $319.86 million. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%. The firm’s revenue was up 4.4% compared to the same quarter last year. During the same period last year, the business posted $0.26 earnings per share. Sell-side analysts anticipate that Sotera Health will post 0.87 EPS for the current year.

Insider Buying and Selling at Sotera Health

In other news, Chairman Michael B. Jr. Petras sold 850,000 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $18.50, for a total transaction of $15,725,000.00. Following the sale, the chairman directly owned 3,969,393 shares in the company, valued at approximately $73,433,770.50. The trade was a 17.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 15.36% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of SHC. Darsana Capital Partners LP increased its holdings in Sotera Health by 3.8% in the 2nd quarter. Darsana Capital Partners LP now owns 27,000,000 shares of the company’s stock valued at $479,250,000 after buying an additional 1,000,000 shares during the period. BlackRock Inc. bought a new position in shares of Sotera Health during the 2nd quarter worth about $428,635,000. Sculptor Capital LP acquired a new stake in shares of Sotera Health during the 2nd quarter valued at about $426,000,000. Janus Henderson Group PLC boosted its position in shares of Sotera Health by 35.3% during the 1st quarter. Janus Henderson Group PLC now owns 9,162,191 shares of the company’s stock valued at $131,413,000 after acquiring an additional 2,390,132 shares in the last quarter. Finally, Jupiter Topco LLC bought a new stake in Sotera Health in the second quarter valued at about $149,137,000. 91.03% of the stock is owned by institutional investors.

Sotera Health Company Profile

Sotera Health Company (NASDAQ: SHC) is a healthcare services company focused on sterilization, laboratory testing and infection prevention. Its services support manufacturers and providers across the medical device, pharmaceutical, tissue, food safety and other healthcare-related industries.

The company operates through three primary businesses. Sterigenics provides outsourced sterilization services, including ethylene oxide, gamma irradiation and electron-beam processing. Nelson Labs offers laboratory testing, analytical services and consulting for medical devices, pharmaceuticals and other healthcare products.